Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Cash from Financing Activities (2023 - 2025)

Historic Cash from Financing Activities for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $760000.0.

  • Upstream Bio's Cash from Financing Activities rose 14631.32% to $760000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $272.0 million, marking a year-over-year increase of 8361.43%. This contributed to the annual value of $418.9 million for FY2024, which is 22335.78% up from last year.
  • According to the latest figures from Q3 2025, Upstream Bio's Cash from Financing Activities is $760000.0, which was up 14631.32% from $612000.0 recorded in Q2 2025.
  • Upstream Bio's 5-year Cash from Financing Activities high stood at $270.6 million for Q4 2024, and its period low was -$1.6 million during Q3 2024.
  • Moreover, its 3-year median value for Cash from Financing Activities was $686000.0 (2025), whereas its average is $52.5 million.
  • In the last 5 years, Upstream Bio's Cash from Financing Activities soared by 20359473.68% in 2024 and then crashed by 10036.22% in 2025.
  • Over the past 3 years, Upstream Bio's Cash from Financing Activities (Quarter) stood at -$133000.0 in 2023, then surged by 203594.74% to $270.6 million in 2024, then tumbled by 99.72% to $760000.0 in 2025.
  • Its Cash from Financing Activities stands at $760000.0 for Q3 2025, versus $612000.0 for Q2 2025 and -$34000.0 for Q1 2025.